Biotechnology News
Enbrel and the Autoimmune Era
13 hrs ago | theatlantic.comEnbrel is one of the top ten drugs in the U.S. by sales, garnering the pharmaceutical giants who co-market the drug, Amgen and Pfizer, billions of dollars in revenue annually. People take Enbrel for inflammatory conditions like...
Read more...
Why Washington Fears Iran
12 hrs ago | popularresistance.orgWhile the Iranian economy struggles to adjust to periodic US sanctions “upgrades,” a significantly devalued currency and restrictions in global financial transactions have suddenly challenged even Iran’s famed adaptability to...
Read more... All similar articles: 1743 »
An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
12 hrs ago | yahoo.comJun 18 2013, 11:34 by: Joseph Allen | includes: If you have any acquaintance with the biotech and small pharma market, you know who Dr. Elemer Piros is. Top-ranked by the Wall Street Journal and Financial Times in different...
Read more...Where Is Biotechnology's Next 'Anti-PD-1'?
16 hrs ago | seekingalpha.comJun 18 2013, 07:57 by: Brian Nichols | includes: Every so often a treatment method takes the market by storm and leads to unexpected gains for the biotechnology companies who are developing it. In 2011, we saw this happen with...
Read more...ACTIVAERO RECEIVES RESEARCH GRANT FOR DEVELOPMENT OF THERAPY AGAINST CHRONIC LUNG DISEASES
18 hrs ago | firmenpresse.deActivaero GmbH / ACTIVAERO RECEIVES RESEARCH GRANT FOR DEVELOPMENT OF THERAPY AGAINST CHRONIC LUNG DISEASES . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this...
Read more...
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
12 hrs ago | trefis.comSubmitted by Scott Matusow as part of our contributors program. Glucose is one of the most important chemical structures because it is essential in providing the body with energy. It is integral in the chemical process called...
Read more...Transdifferentiation of Fast Skeletal Muscle Into Functional Endothelium in Vivo by Transcription...
5 hrs ago | plosbiology.orgby Matthew B. Veldman, Chengjian Zhao, Gustavo A. Gomez, Anne G. Lindgren, Haigen Huang, Hanshuo Yang, Shaohua Yao, Benjamin L. Martin, David Kimelman, Shuo Lin Etsrp/Etv2 (Etv2) is an evolutionarily conserved master regulator...
Read more...Global Nanobiotechnology Applications, Markets and Companies Market Report - 2013-2022
10 hrs ago | sacbee.comPublished: Tuesday, Jun. 18, 2013 - 10:47 am DUBLIN, June 18, 2013 -- /PRNewswire/ -- Research and Markets has announced the addition of the report "Nanobiotechnology Applications, Markets and Companies" to their offering....
Read more...
Maria De Wind favorited 14300's discussion Biofarms’ to Integrate Vaccines, Pharmaceuticals into...
2 hrs ago | 12160.infoBiofarms’ to Integrate Vaccines, Pharmaceuticals into GMO ‘Biopharm... The truth really is much stranger than fiction, especially when it comes to the open and admitted future plans of major biotechnology companies. One such...
Read more...GLEQ Business Plan Competition Awards $216k To Michigan Technology Entrepreneurs
43 mins ago | cbslocal.comThe Great Lakes Entrepreneur’s Quest hosted its 13th annual statewide business plan competition awards event for technology ventures at Entrepreneur Connect 2013 on Tuesday, June 18, at the James B. Henry Center on the Michigan...
Read more...NKT Cell-TCR Expression Activates Conventional T Cells in Vivo, but Is Largely Dispensable for...
5 hrs ago | plosbiology.orgby J. Christoph Vahl, Klaus Heger, Nathalie Knies, Marco Y. Hein, Louis Boon, Hideo Yagita, Bojan Polic, Marc Schmidt-Supprian Natural killer T (NKT) cell development depends on recognition of self-glycolipids via their...
Read more...
China Intent On Producing Genetically Modified Cow Milk To Replace Human Breast Milk And Sold At...
17 hrs ago | oneradionetwork.comPrevent Disease Scientists have now successfully introduced human genes into 300 dairy cows in a bid to produce a cow milk alternative to human breast milk. The biotech company has high hopes that genetically modified dairy...
Read more...New Study Links GMO Food To Leukemia
5 hrs ago | misebogland.wordpress.comA new study, yet to receive any media attention, reveals the “leukemogenic” properties of the Bt toxin biopesticides engineered into the vast majority of GMO food crops already within the US food supply. Last September, the...
Read more...
Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate...
11 hrs ago | sacbee.comPublished: Tuesday, Jun. 18, 2013 - 10:12 am NEW YORK, June 18, 2013 -- /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Lab Automation Market by Equipment & Software...
Read more...
The Top 3 Medical Uses of Botox
4 hrs ago | dailyfinance.comFiled under: Investing Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community. Since it was first approved for two eye muscle...
Read more...
Techne Corporation Announces Acquisition Agreement
9 hrs ago | bioportfolio.comMINNEAPOLIS June 18 2013 PRNewswire &160;Techne Corporation NASDAQ TECH Techne announced today that it has agreed to acquire 100 ownership of Bionostics Holdings Limited and its operating subsidiary Bionostics Inc....
Read more...Obafemi Awolowo University, OAU Massive Recruitment for Academic and Non-Teaching Positions
21 hrs ago | ngscholars.comObafemi Awolowo University, OAU is currently recruiting massively for Academic and Non-Teaching Positions for both Graduate & Senior Academic and Non-academic Levels. Obafemi Awolowo University, Ile Ife invite applications from...
Read more...
Index Ventures closes its biggest life sciences investment in heart attack prevention drug
12 hrs ago | growthbusiness.co.ukAn $11 million investment from Index Ventures will be used to develop an anticoagulant drug aimed at preventing heart attacks and strokes without causing bleeding. Index Ventures has made a second commitment from its $200...
Read more... All similar articles: 51 »Cellectis SA Combined General Shareholders Meeting of June 14 2013
11 hrs ago | bioportfolio.comApproval of the 18 resolutions proposed by the Board of Directors Dr Mathieu Simon, Senior Vice President and CEO of Cellectis therapeutics, elected to the Board of Directors of Cellectis SA Related Biotechnology,...
Read more...
OMICS to CoPublish Open Access Journals with AstonJournals
7 hrs ago | bioportfolio.comHenderson NV June 18 2013 PR.com OMICS Group Inc. omicsonline.org is pleased to announce the signing of copartnership agreement. This latest arrangement establishes OMICS as coPublisher with the AstonJournals The announcement...
Read more...Kineta and Rosa form strategic alliance for next stage of clinical development of lead drug...
7 hrs ago | drugs.comSEATTLE, WA, June 14, 2013 - Kineta, Inc. a biotechnology company focused on the development of novel modulating drugs for critical disease areas, announced today a strategic alliance with Rosa & Co. LLC (www.rosaandco.com), a...
Read more...AOP Orphan Spins Off Its Stake in Activartis and Outlines Business Strategy
19 hrs ago | checkorphan.orgAOP Orphan Pharmaceuticals AG announced the spin off of its 80 % stake in Activartis GmbH, a Vienna-based biotech company with a strong platform for immune-based cancer vaccines, to a group of private investors. The dendritic...
Read more...
Comment on Is Movement to Label GMOs Anti-Science? by JoeWeinstein
7 hrs ago | laprogressive.comThe best defense is a good offense. Monsanto et al know that failure to take precautions in regards new and not fully tested technology is itself bad science-application policy. So they go on the offensive and denounce labeling...
Read more...BioRestorative Therapies, Inc. (BRTX) CEO Mark Weinreb Details Biotech Innovation in NBT Equities...
14 hrs ago | qualitystocks.netBioRestorative Therapies CEO Mark Weinreb was recently interviewed by financial personality and founder of NBT Equities Research, Tobin Smith, to discuss the life science company’s medical procedures using cell and tissue...
Read more...
A new highenergy record for LCLS
40 mins ago | bioportfolio.comRelated Biotechnology, Pharmaceutical and Healthcare News Read more about A new high-energy record for LCLSComments Searches Linking to this Story Latest Biotechnology, Pharmaceutical and Healthcare News HbA1c Far From Perfect...
Read more... All similar articles: 85 »
Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life and Help Students Explore...
15 hrs ago | finance.yahoo.comtoday announced more than $500,000 in new grants to more than a dozen educational institutions and organizations working to enhance the teaching and learning of science, technology, engineering and mathematics (STEM) in K-12...
Read more...
Expanding Switzerland’s ‘Health Valley’
18 hrs ago | tageswoche.chBacked by billionaires, a major new biotech research initiative in Geneva dubbed ‘Campus Biotech’ looks set to shift Switzerland’s ‘Health Valley’ up a gear. Coming after major job losses in the region, it is receiving a...
Read more...
Researchers engineer synthetic pathways for new antibacterial treatments
17 hrs ago | europa.euBacteria, for the most part, thrive in extreme temperatures and in arid conditions. But some types of bacteria have the capacity to do this and more: they grow within diverse environments and adapt easily. One such species is...
Read more...Thomas A. Shea Joins EPIRUS Biopharmaceuticals as Chief Financial Officer
11 hrs ago | fortmilltimes.comEPIRUS Biopharmaceuticals, Inc. (EPIRUS), a privately held biotechnology company focused on the development and production of biosimilar products in and for major emerging markets, today announced the appointment of Thomas Shea...
Read more...Where Is Biotechnology's Next 'AntiPD1'
15 hrs ago | bioportfolio.comBy Brian NicholsEvery so often a treatment method takes the market by storm and leads to unexpected gains for the biotechnology companies who are developing it. In 2011 we saw this happen with hepatitis C companies such as...
Read more...